RPG Life Sciences Limited
quarterly
yearly
| Particulars | Jun '21 | Sep '21 | Dec '21 | Mar '22 | Jun '22 |
|---|---|---|---|---|---|
| Revenue | 108.13 | 112.65 | 115.58 | 103.80 | 128.93 |
| Expenses | 89.14 | 90.84 | 95.41 | 94.07 | 104.92 |
| EBITDA | 18.99 | 21.81 | 20.17 | 9.73 | 24.01 |
| EBIT | 15.03 | 17.82 | 16.24 | 5.95 | 20.18 |
| Profit Before Tax | 19.27 | 22.35 | 20.62 | 10.93 | 25.12 |
| Net Profit | 13.58 | 15.75 | 14.63 | 7.52 | 18.21 |
| Financial Ratios | |||||
| Operating Profit Margin | 17.56% | 19.36% | 17.45% | 9.37% | 18.62% |
| Net Profit Margin | 12.56% | 13.98% | 12.66% | 7.24% | 14.12% |
| Earning Per Share (Diluted) | 8.21 | 9.52 | 8.85 | 4.55 | 11.01 |
| Dividends Per Share | NA | NA | NA | 9.60 | NA |
